Your browser doesn't support javascript.
loading
Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis.
Elliott, Colm; Rudko, David A; Arnold, Douglas L; Fetco, Dumitru; Elkady, Ahmed M; Araujo, David; Zhu, Bing; Gafson, Arie; Tian, Zhe; Belachew, Shibeshih; Bradley, Daniel P; Fisher, Elizabeth.
  • Elliott C; NeuroRx Research, Montreal, QC, Canada.
  • Rudko DA; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada/McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, Montreal, QC, Canada/Department of Biomedical Engineering, McGill University, Montreal, QC, Canada.
  • Arnold DL; NeuroRx Research, Montreal, QC, Canada/Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
  • Fetco D; NeuroRx Research, Montreal, QC, Canada/Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
  • Elkady AM; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada/McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, Montreal, QC, Canada/Department of Biomedical Engineering, McGill University, Montreal, QC, Canada.
  • Araujo D; NeuroRx Research, Montreal, QC, Canada/Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
  • Zhu B; Biogen, Cambridge, MA, USA.
  • Gafson A; Biogen, Cambridge, MA, USA.
  • Tian Z; Biogen, Cambridge, MA, USA.
  • Belachew S; Biogen, Cambridge, MA, USA.
  • Bradley DP; Biogen, Cambridge, MA, USA.
  • Fisher E; Biogen, Cambridge, MA, USA.
Mult Scler ; 29(6): 680-690, 2023 05.
Article en En | MEDLINE | ID: mdl-37036134
ABSTRACT

BACKGROUND:

Paramagnetic rim lesions (PRLs) and slowly expanding lesions (SELs) have been posited as markers of chronic active lesions (CALs).

OBJECTIVE:

To assess the lesion-level concordance of PRLs and SELs in MS and to characterize changes in brain tissue integrity in CALs over time.

METHODS:

MRIs were analyzed from a substudy of AFFINITY [NCT03222973], a phase 2 trial of opicinumab in relapsing MS. Assessments included (1) identification of SELs based on longitudinal MRIs over 72 weeks, and identification of PRLs on susceptibility-weighted imaging (SWI) filtered phase images at week 72; (2) evaluation of subject-level correlation of SEL and PRL counts, volumes, and degree of lesion-level overlap between SELs and PRLs; and (3) characterization of tissue integrity over time in overlapping and non-overlapping SELs and PRLs.

RESULTS:

In 41 subjects, 119 chronic PRLs and 267 SELs were detected. Of 119 (39.5%) chronic PRLs, 47 co-localized with a SEL; 46/267 (17.2%) SELs co-localized with a PRL. PRLs co-localized with SELs showed expansion and worsening microstructural damage over time. SELs with and without co-localization with PRLs showed ongoing tissue damage.

CONCLUSIONS:

Chronic MS lesions identified as both PRL and SEL were associated with the most severe accumulation of tissue damage. TRIAL REGISTRATION AFFINITY [NCT03222973].
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article